GABA potentiation: A logical pharmacological approach for the treatment of acute ischaemic stroke

Neuropharmacology

Volumn 39, Issue 9, 2000, Pages 1483-1494

  Green, A Richard ^a,b   Hainsworth, Atticus H ^b   Jackson, David M ^c  

^a ASTRAZENECA   (United Kingdom)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cerebral ischaemia; Clomethiazole; GABA and neuroprotection; GABAmimetics; Muscimol; Neuroprotection; Stroke

Indexed keywords

1 [2 [4,4' BIS(TRIFLUOROMETHYL)BENZHYDRYLOXY]ETHYL] 1,2,5,6 TETRAHYDRO 3 PYRIDINECARBOXYLIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CLOMETHIAZOLE; DIZOCILPINE; MUSCIMOL; RECEPTOR SUBTYPE;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ANIMAL MODEL; CEREBROVASCULAR ACCIDENT; GABAERGIC SYSTEM; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ACUTE DISEASE; ANIMALS; BRAIN; BRAIN ISCHEMIA; CHLORMETHIAZOLE; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MUSCIMOL; NEUROPROTECTIVE AGENTS; RECEPTORS, GABA-A;

EID: 0034078117     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00233-6     Document Type: Review

References (111)

1. Abel M.S., McCandless D.W. Elevated gamma-aminobutyric acid levels attenuate the metabolic response to bilateral ischemia. Journal of Neurochemistry. 58:1992;740-744.
2. Baldwin H.A., Jones J.A., Cross A.J., Green A.R. Histological biochemical and behavioural evidence for the neuroprotective actions of chlormethiazole following prolonged carotid artery occlusion. Neurodegeneration. 2:1993;139-146.
3. Baldwin H.A., Williams J.L., Snares M., Ferreira T., Cross A.J., Green A.R. Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat. British Journal of Pharmacology. 112:1994;188-194.
4. A receptors: classification on the basis of subunit structure and receptor function. Pharmacological Reviews. 50:1998;291-313.
5. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. Journal of Neurochemistry. 43:1984;1369-1374.
6. Bonita R. Epidemiology of stroke. Lancet. 339:1992;342-344.
7. C receptors. Trends in Neurosciences. 18:1995;515-519.
8. Bowdler J.M., Green A.R. Regional rat brain benzodiazepine receptor number and y-aminobutyric acid concentrations following a convulsion. British Journal of Pharmacology. 76:1982;291-298.
9. Brown A.W., Levy D.E., Kublik M., Harrow J., Plum F., Brierley J.B. Selective chromatolysis of neurons in the gerbil brain: a possible consequence of 'epileptic' activity produced by common carotid artery occlusion. Annals of Neurology. 5:1979;127-138.
10. Buchan A.M., Slivka A., Xue D. The effect of the NMDA receptor antagonist MK801 on cerebral blood flow and infarct volume inexperimental focal stroke. Journal of Phsysiology. 482(2):1992;353-362.
11. Colado M.I., Granados R., O'Shea E., Esteban B., Green A.R. Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR. British Journal of Pharmacology. 124:1998;479-484.
12. Colado M.I., Murray T.K., Green A.R. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. British Journal of Pharmacology. 108:1993;583-589.
13. A receptor diversity emerges a unified vision of GABAertic inhibition. Annual Review of Pharmacology and Toxicology. 38:1998;321-350.
14. Coyle J.T. Neurotoxic action of kainic acid. Journal of Neurochemistry. 41:1983;1-11.
15. Cross A.J., Anderson S.M.P., John V.H., De Souza R.J., Green A.R. Clomethiazole attenuates hypoxia-induced damage to rat cerebellar granule cells in vitro. British Journal of Pharmacology. 126:1999;294P.
16. Cross A.J., Jones J.A., Baldwin H.A., Green A.R. Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbil. British Journal of Pharmacology. 104:1991;406-411.
17. Cross A.J., Jones J.A., Snares M., Jostell K.G., Bredberg U., Green A.R. The protective action of chlormethiazole against ischaemia-induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity. British Journal of Pharmacology. 114:1995;1625-1630.
18. Cross A.J., Snape M.F., Green A.R. Chlormethiazole antagonises seizures induced by N-methyl-DL-aspartate without interacting with the NMDA receptor complex. Psychopharmacology. 112:1993;403-406.
19. A-receptor complex in rat brain. British Journal of Pharmacology. 98:1989;284-290.
20. During M.J., Ryder K.M., Spencer D.D. Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature. 376:1995;174-177.
21. Farooque M., Isaksson J., Jackson D.M., Olsson Y. Clomethiazole (Zendra®, CMZ) improves hind limb motor function and reduces neuronal damage after severe spinal cord injury in rat. Acta Neuropathologica. 98:1999;22-30.
22. Farrar S.J., Whiting P.J., Bonnert T., McKernan R.M. Stoichiometry of a ligand-gated ion channel determined by fluorescence energy transfer. Journal Biological Chemistry. 274:1999;10100-10104.
23. Gilby, K.L., Robertson, H.A., 1998. Clomethiazole-induced neuroprotection against ischemic insults is not achieved through induction of HSP25, HSP40 or HSP70. Society for Neuroscience Abstract 87,15.
24. Gill R., Foster A.C., Woodruff G.N. MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period. Neuroscience. 25:1988;847-855.
25. Glitsch M., Llano I., Marty A. Glutamate as a candidate retrograde messenger at interneurone-Purkinje cell synapses of rat cerebellum. Journal of Phsysiology. 497(2):1996;531-537.
26. Green A.R. Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy. Pharmacology and Therapeutics. 80:1998;123-147.
27. Green A.R., Cross A.J. Attenuation by chlormethiazole of oedema following focal ischaemia in the cerebral cortex of the rat. Neuroscience Letters. 173:1994;27-30.
28. Green A.R., Cross A.J. Techniques for examining neuroprotective drugs in vivo. International Review of Neurobiology. 40:1997;47-68.
29. Green A.R., Cross A.J. Neuroprotective agents and cerebral ischaemia. 1997;Academic Press, London.
30. Green A.R., Murray T.K. A simple intravenous infusion method in rodents for determining the potency of anticonvulsants acting through GABAergic mechanisms. Journal of Pharmacy and Pharmacology. 41:1989;879-880.
31. Green A.R., Cross A.J., Snape M.F., De Souza R.J. The immediate consequences of middle cerebral artery occlusion on GABA synthesis in mouse cortex and cerebellum. Neuroscience Letters. 138:1992;141-144.
32. Green A.R., De Souza R.J., Williams J.L., Murray T.K., Cross A.J. The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole. Neuropharmacology. 31:1992;315-321.
33. Green A.R., Metz A., Minchin M.C.W., Vincent N.D. Inhibition of the rate of GABA synthesis in regions of rat brain following a convulsion. British Journal of Pharmacology. 92:1987;5-11.
34. Green A.R., Minchin M.C.W., Vincent N.D. Inhibition of GABA release from slices prepared from several brain regions of rats at various times following a convulsion. British Journal of Pharmacology. 92:1987;13-18.
35. Green A.R., Misra A., Hewitt K.E., Snape M.F., Cross A.J. An investigation of the possible interaction of clomethiazole with glutamate and ion channel sites as an explanation of its neuroprotective activity. Pharmacology and Toxicology. 83:1998;90-94.
36. A receptor. Neuropharmacology. 35:1996;1243-1250.
37. Hagberg H., Lehmann A., Sandberg M., Nystrom B., Jacobson I., Hamberger A. Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. Journal of Cerebral Blood Flow and Metabolism. 5:1985;413-419.
38. A and glycine receptors by chlormethiazole. European Journal of Pharmacology. 210:1992;239-246.
39. A receptor complex in rat cuneate nucleus in vitro. British Journal of Pharmacology. 80:1983;387-394.
40. Hunter A.J., Green A.R., Cross A.J. Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs? Trends in Pharmacological Sciences. 16:1995;123-128.
41. Inglefield J.R., Perry J.M., Schwartz R.D. Postischemic inhibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus. Hippocampus. 5:1995;460-468.
42. A receptors. Acta Anaesthesiologica Scandinavica. 43:1999;153-162.
43. Jackson-Friedman C., Lyden P.D., Nunez S., Jin A., Zweifler R. High dose baclofen is neuroprotective but also causes intracerebral hemorrhage: a quantal bioassay study using the intraluminal suture occlusion method. Experimental Neurology. 147:1997;346-352.
44. Johansen F.F., Diemer N.H. Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduces loss of hippocampal CA1 pyramidal cells. Acta Neurologica Scandinavica. 84:1991;1-6.
45. Johansen F.F., Christensen T., Jensen M.S., Valente E., Jensen C.V., Nathan T., Lambert J.D., Diemer N.H. Inhibition in postischemic rat hippocampus: GABA receptors, GABA release, and inhibitory postsynaptic potentials. Experimental Brain Research. 84:1991;529-537.
46. A-mediated IPSP regulates facilitation of NMDA-mediated responses to burst stimulation of afferent fibers in piriform cortex. Journal of Neuroscience. 16:1996;307-312.
47. Kanthan R., Shuaib A., Griebel R., Miyashita H. Intracerebral human microdialysis. In vivo study of an acute focal ischemic model of the human brain. Stroke. 26:1995;870-873.
48. Lees K.R. Does neuroprotection improve stroke outcome? Lancet. 351:1998;1447-1448.
49. Liang S.P., Kanthan R., Shuaib A., Wishart T. Effects of clomethiazole on radial-arm maze performance following global forebrain ischemia in gerbils. Brain Research. 751:1997;189-195.
50. Lyden P.D. GABA and neuroprotection. International Review of Neurobiology. 40:1997;233-258.
51. Lyden P.D., Hedges B. Protective effect of synaptic inhibition during cerebral ischemia in rats and rabbits. Stroke. 23:1992;1463-1469.
52. Lyden P.D., Lonzo L. Combination therapy protects ischemic brain in rats. A glutamate antagonist plus a gamma-aminobutyric acid agonist. Stroke. 25:1994;189-196.
53. Lyden P., Lonzo L., Nunez S. Combination chemotherapy extends the therapeutic window to 60 minutes after stroke. Journal of Neurotrauma. 12:1995;223-230.
54. Lyden, P., Shin, C., Jackson-Friedman, C., Hassid, S., Chong, A., 2000. Neuprotective effect of ganaxolone in a rodent model of cerebral haematoma. Stroke (in press).
55. MacDermott A.B., Role L.W., Siegelbaum S.A. Presynaptic ionotropic receptors and the control of transmitter release. Annual Review of Neuroscience. 22:1999;443-485.
56. MacGregor D.G., Graham D.I., Stone T.W. The attenuation of kainate-induced neurotoxicity by chlormethiazole and its enhancement by dizocilpine, muscimol, and adenosine receptor agonists. Experimental Neurology. 148:1997;110-123.
57. Macrae I.M. New models of focal cerebral ischemia. British Journal Clinical Pharmacology. 34:1992;302-308.
58. Madden K.P. Effect of gamma-aminobutyric acid modulation on neuronal ischemia in rabbits. Stroke. 25:1994;2271-2274.
59. Mainprize T., Shuaib A., Ijaz S., Kanthan R., Miyashita H., Kalra J. GABA concentrations in the striatum following repetitive cerebral ischemia. Neurochemical Research. 20:1995;957-961.
60. Manuel N.A., Davies C.H. Pharmacological modulation of GABA(A) receptor-mediated postsynaptic potentials in the CA1 region of the rat hippocampus. British Journal of Pharmacology. 125:1998;1529-1542.
61. Marshall J.W., Cross A.J., Murray T.K., Ridley R.M. Clomethiazole treatment ameliorates the motor disability incurred by focal cerebral ischaemia in a non-human primate. Experimental Neurology. 156:1998;121-129.
62. Marty A., Llano I. Modulation of inhibitory synapses in the mammalian brain. Current Opinion in Neurobiology. 5:1995;335-341.
63. A receptors. Brain Research Reviews. 29:1999;196-217.
64. Meldrum B. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovascular and Brain Metabolism Reviews. 2:1990;27-57.
65. Moody E.J., Skolnick P. Chlormethiazole: neurochemical actions at the gamma-aminobutyric acid receptor complex. European Journal of Pharmacology. 164:1989;153-158.
66. Morishita W., Kirov S.A., Alger B.E. Evidence for metabotropic glutamate receptor activation in the induction of depolarization-induced suppression of inhibition in hippocampal CA1. Journal of Neuroscience. 18:1998;4870-4882.
67. Muir K.W., Grossett D.G. Neuroprotection for acute stroke: making clinical trials work. Stroke. 30:1999;180-182.
68. Nelson R.M., Sprague J., Green A.R., Hainsworth A.H. Gluatmate release from rat brain slices in response of hypoxia/aglycaemia: inhibition by clomethiazole and GABA. British Journal of Pharmacology. 128:1999;183P.
69. Nitsch C., Goping G., Klatzo I. Preservation of GABAergic perikarya and boutons after transient ischemia in the gerbil hippocampal CA1 field. Brain Research. 495:1989;243-252.
70. Ohkuma S., Chen S.H., Katsura M., Chen D.Z., Kuriyama K. Muscimol prevents neuronal injury induced by NMDA. Japanese Journal of Pharmacology. 64:1994;125-128.
71. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 244:1989;1360-1362.
72. Phillis J.W. CI-966, a GABA uptake inhibitor, antagonizes ischemia-induced neuronal degeneration in the gerbil. General Pharmacology. 26:1995;1061-1064.
73. Phillis J.W., Perkins L.M., Smith-Barbour M., O'Regan M.H. Transmitter amino acid release from rat neocortex: complete versus incomplete ischemia models. Neurochemical Research. 19:1994;1387-1392.
74. Phillis J.W., Smith-Barbour M., O'Regan M.H., Perkins L.M. Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion. Neurochemical Research. 19:1994;1125-1130.
75. Ravindran J., Shuaib A., Ijaz S., Galazka P., Waqar T., Ishaqzay R., Miyashita H., Liu L. High extracellular GABA levels in hippocampus - as a mechanism of neuronal protection in cerebral ischemia in adrenalectomized gerbils. Neuroscience Letters. 176:1994;209-211.
76. Richards J.G., Schoch P., Haring P., Takacs B., Mohler H. Resolving GABAA/benzodiazepine receptors: cellular and subcellular localization in the CNS with monoclonal antibodies. Journal of Neuroscience. 7:1987;1866-1886.
77. Riveros N., Orrego F. N-methylasparate-activated calcium channels in rat brain cortex slices. Effects of calcium channel blockers and of inhibitory and depressant substances. Neuroscience. 17:1999;541-546.
78. Rosenbaum D.M., Grotta J.C., Pettigrew L.C., Ostrow P., Strong R., Rhoades H., Picone C.M., Grotta A.T. Baclofen does not protect against cerebral ischemia in rats. Stroke. 21:1990;138-140.
79. Rudomin P. Presynaptic inhibition of muscle spindle and tendon organ afferents in the mammalian spinal cord. Trends in Neurosciences. 13:1990;499-505.
80. Saji M., Reis D.J. Delayed transneuronal death of substantia nigra neurons prevented by gamma-aminobutyric acid agonist. Science. 235:1987;66-69.
81. Schwartz-Bloom R.D., McDonough K.J., Chase P.J., Chadwick L.E., Inglefield J.R., Levin E.D. Long-term neuroprotection by benzodiazepine full versus partial agonists after transient cerebral ischemia in the gerbil. Journal of Cerebral Blood Flow and Metabolism. 18:1998;548-558.
82. Schwartz R.D., Huff R.A., Yu X., Carter M.L., Bishop M. Postischemic diazepam is neuroprotective in the gerbil hippocampus. Brain Research. 647:1994;153-160.
83. Schwartz R.D., Yu X., Katzman M.R., Hayden-Hixson D.M., Perry J.M. Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum. Journal of Neuroscience. 15:1995;529-539.
84. Scotti DeCarolis S.A., Lipprinai F., Longo V.G. Neuropharmacological investigations on muscimol a psychotropic drug extracted from Amanita muscaria. Psychopharmacologia. 15:1969;186-195.
85. Shuaib A., Ijaz S., Hasan S., Kalra J. Gamma-vinyl GABA prevents hippocampal and substantia nigra reticulata damage in repetitive transient forebrain ischemia. Brain Research. 590:1992;13-17.
86. Shuaib A., Ijaz S., Kanthan R. Clomethiazole protects the brain in transient forebrain ischemia when used up to 4 h after the insult. Neuroscience Letters. 197:1995;109-112.
87. Shuaib A., Ijaz S., Miyashita H., Mainprize T., Kanthan R. Progressive decrease in extracellular GABA concentrations in the post-ischemic period in the striatum: a microdialysis study. Brain Research. 666:1994;99-103.
88. Shuaib A., Mazagri R., Ijaz S. GABA agonist 'muscimol' is neuroprotective in repetitive transient forebrain ischemia in gerbils. Experimental Neurology. 123:1993;284-288.
89. Shuaib A., Murabit M.A., Kanthan R., Howlett W., Wishart T. The neuroprotective effects of gamma-vinyl GABA in transient global ischemia: a morphological study with early and delayed evaluations. Neuroscience Letters. 204:1996;1-4.
90. Shuaib A., Waqar T., Ijaz M.S., Kanthan R., Wishart T., Howlett W. Neuroprotection with felbamate: a 7- and 28-day study in transient forebrain ischemia in gerbils. Brain Research. 727:1996;65-70.
91. A receptor subtypes. Pharmacological Reviews. 47:1995;181-234.
92. Simon R.P., Swan J.H., Medrum B.S. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 226:1984;850-852.
93. Slany A., Zezula J., Tretter V., Sieghart W. Rat beta 3 subunits expressed in human embryonic kidney 293 cells form high affinity [35S]t-butylbicyclophosphorothionate binding sites modulated by several allosteric ligands of gamma-aminobutyric acid type A receptors. Molecular Pharmacology. 48:1995;385-391.
94. Small D.L., Buchan A.M. NMDA antagonists: their role in neuroprotection. International Review of Neurobiology. 40:1997;137-171.
95. Snape M.F., Baldwin H.A., Cross A.J., Green A.R. The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat. Neuroscience. 53:1993;837-844.
96. A receptors in the cerebellum of rat, cat, and monkey using monoclonal antibodies. Journal of Neuroscience. 9:1989;2197-2209.
97. + stimulated release of glutamate from mouse cortex. European Journal of Pharmacology. 315:1996;285-288.
98. Sternau L.L., Lust W.D., Ricci A.J., Ratcheson R. Role for gamma-aminobutyric acid in selective vulnerability in gerbils. Stroke. 20:1989;281-287.
99. Sydserff S.G., Cross A.J., Green A.R. The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat. Neurodegeneration. 4:1995;323-328.
100. Sydserff S.G., Cross A.J., West K.J., Green A.R. The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia. British Journal of Pharmacology. 114:1995;1631-1635.
101. Sydserff S.G., Green A.R., Cross A.J. The effect of oedema and tissue swelling on the measurement of neuroprotection; a study using chlormethiazole and permanent middle cerebral artery occlusion in rats. Neurodegeneration. 5:1996;81-85.
102. Tecoma E.S., Choi D.W. GABAergic neocortical neurons are resistant to NMDA receptor-mediated injury. Neurology. 39:1989;676-682.
103. Thaminy S., Reymann J.M., Heresbach N., Allain H., Lechat P., Bentue-Ferrer D. Is chlormethiazole neuroprotective in experimental global cerebral ischemia? A microdialysis and behavioral study. Pharmacology, Biochemistry and Behavior. 56:1997;737-745.
104. Thóren P., Sjölander M. Chlormethiazole attenuates the derangement of sensory evoked potential (SEP) induced by ICV administration of NMDA. Psychopharmacology. 111:1993;256-258.
105. Voll C.L., Auer R.N. Insulin attenuates ischemic brain damage independent of its hypoglycemic effect. Journal of Cerebral Blood Flow and Metabolism. 11:1991;1006-1014.
106. Voll C.L., Auer R.N. Postischemic seizures and necrotizing ischemic brain damage: neuroprotective effect of postischemic diazepam and insulin. Neurology. 41:1991;423-429.
107. Wahlgren N.G., Ranaasinha K.W., Rosolacci T., Francke C.L., vanErven P.M.M., Ashwood T., Claesson L. The clomethiazole acute stroke study (CLASS): efficacy results in a subgroup of 545 patients with total anterior circulation syndrome. Stroke. 30:1999;21-28.
108. Zezula J., Slany A., Sieghart W. Interaction of allosteric ligands with GABAA receptors containing one, two, or three different subunits. European Journal of Pharmacology. 301:1996;207-214.
109. Zhang S.J., Jackson M.B. GABA-activated chloride channels in secretory nerve endings. Science. 259:1993;531-534.
110. Zhong Y., Simmonds M.A. Interactions between loreclezole, chlormethiazole and pentobarbitone at GABA(A) receptors: functional and binding sites. British Journal of Pharmacology. 121:1997;1392-1396.
111. Zivin J.A., DeGirolami U. Spinal cord infarction: a highly reproducible stroke model. Stroke. 11:1980;200-202.